DocGo Inc. Stock News

NEW YORK--(BUSINESS WIRE)--DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, Chief Executive Officer will present at three differen

DocGo Inc. (NASDAQ:DCGO ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Corporate Participants Mike Cole - Director-Investor Relations Anthony Capone - Chief Executive Officer Lee Biensto

DocGo Inc. (DCGO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.07 per share a year ago.

Two new Breakout Stocks for Week 31 curated by the MDA model for 10% short-term upside and additional model selections. This week two of four picks gained over 10% in less than a week with peak gains

NEW YORK--(BUSINESS WIRE)--DocGo Inc., a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the second quarter ended June 30,

DocGo Inc. (DCGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the

DocGo delivered what analysts at Canaccord called “mixed” results, but that was enough for the firm to reiterate its Buy rating and $13 price target.  “At first glance, DocGo's 1Q results can b

DocGo, Inc. (DGCO) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Mike Cole – Director-Investor Relations Anthony Capone – Chief Executive Officer Lee Bienstock – P

NEW YORK--(BUSINESS WIRE)--DocGo will announce Q1 2023 results on Monday, May 8th, via conference call.

We saw our previous prediction of municipal contracts helping cushion DocGo's revenue (absent of the Covid test) work out for its full year of 2022. The technological advantage in operations and low d

DocGo Inc, a last-mile health services company, continues to prove it can successfully replace its COVID testing revenue after it posted 4Q results that beat expectations, according to analysts at Can

DocGo Inc (NASDAQ: DCGO) has emerged as a buyable growth stock for 2023, which is saying something. The fallout from SVB's collapse is yet to be felt and will impact growth names this year.

Start Time: 17:00 January 1, 0000 5:41 PM ET DocGo Inc. (NASDAQ:DCGO ) Q4 2022 Earnings Conference Call March 13, 2023, 17:00 PM ET Company Participants Anthony Capone - CEO Norman Rosenberg - CFO Lee

DocGo Inc. (DCGO) delivered earnings and revenue surprises of 120% and 4.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?